[{"Assets_0_Q1_USD":236482000.0,"CommonStockSharesOutstanding_0_Q1_shares":26908202.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":91691000.0,"NetIncomeLoss_1_Q1_USD":87379000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":26842785.0,"StockholdersEquity_0_Q1_USD":175010000.0,"EarningsPerShareBasic_1_Q1_USD":3.26,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]